New Search

Item 5 of 43 (back to results)
Previous previous next Next
 crotonyl alcohol
C007153
 
  
  
  

MeSH Unique Identifier: C007153
Chemical – Gene Interaction

Note 1: Crotonyl alcohol inhibits the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]

Note 2: Crotonyl alcohol inhibits the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]

Click here for more information

Current search:

Select any link to see items in a related category.

more general categories    information about this item
1. Human Genes 
1. Human Genes
 Acetylcholine receptors, nicotinic [HGNC:CHRN] (130) 
 cholinergic receptor, nicotinic, alpha 2 (neuronal) [HGNC:CHRNA2] (18)
 cholinergic receptor, nicotinic, beta 4 (neuronal) [HGNC:CHRNB4] (32)
 Cholinergic receptors [HGNC:CHR] (184) 
 cholinergic receptor, nicotinic, alpha 2 (neuronal) [HGNC:CHRNA2] (18)
 cholinergic receptor, nicotinic, beta 4 (neuronal) [HGNC:CHRNB4] (32)
2. Interaction: Human Genes and Chemicals 
2. Interaction: Human Genes and Chemicals
 Affects (3990) 
 binding (2423)
 Decreases (5154) 
 reaction (3393)
 Increases (5571) 
 reaction (1574)
 transport (399)
C04. Neoplasms 
C04. Neoplasms
 Neoplasms [MESH:D009369] (10293) 
 Neoplasms by Site [MESH:D009371] (9169) 
 Thoracic Neoplasms [MESH:D013899] (6032) 
 Respiratory Tract Neoplasms [MESH:D012142] (6020) 
 Lung Neoplasms [MESH:D008175] (6015)
C08. Respiratory Tract Diseases 
C08. Respiratory Tract Diseases
 Respiratory Tract Diseases [MESH:D012140] (7881) 
 Lung Diseases [MESH:D008171] (7249) 
 Lung Neoplasms [MESH:D008175] (6012)
 Respiratory Tract Neoplasms [MESH:D012142] (6053) 
 Lung Neoplasms [MESH:D008175] (6013)
C10. Nervous System Diseases 
C10. Nervous System Diseases
 Nervous System Diseases [MESH:D009422] (13325) 
 Central Nervous System Diseases [MESH:D002493] (9745) 
 Brain Diseases [MESH:D001927] (9294) 
 Epilepsy [MESH:D004827] (6274) 
 Seizures [MESH:D012640] (4502)
 Epilepsies, Partial [MESH:D004828] (1267) 
 Epilepsy, Frontal Lobe [MESH:D017034] (172) 
 Epilepsy, Nocturnal Frontal Lobe, Type 4 [MESH:C563679] (43)
 Neurologic Manifestations [MESH:D009461] (8964) 
 Seizures [MESH:D012640] (4514)
 Sleep Disorders [MESH:D012893] (2050) 
 Parasomnias [MESH:D020447] (453) 
 Sleep Arousal Disorders [MESH:D020921] (80) 
 Somnambulism [MESH:D013009] (75) 
 Epilepsy, Nocturnal Frontal Lobe, Type 4 [MESH:C563679] (43)
C23. Pathological Conditions, Signs and Symptoms 
C23. Pathological Conditions, Signs and Symptoms
 Signs and Symptoms [MESH:D012816] (10659) 
 Neurologic Manifestations [MESH:D009461] (8702) 
 Seizures [MESH:D012640] (4502)
C25. Chemically-Induced Disorders 
C25. Chemically-Induced Disorders
 Substance-Related Disorders [MESH:D019966] (6308) 
 Substance Withdrawal Syndrome [MESH:D013375] (2956)
D02. Organic Chemicals 
D02. Organic Chemicals
 Organic Chemicals [MESH:D009930] (75987) 
 Alcohols [MESH:D000438] (4074) 
 Fatty Alcohols [MESH:D005233] (529) 
 Butanols [MESH:D000440] (65)
D10. Lipids 
D10. Lipids
 Lipids [MESH:D008055] (8597) 
 Fatty Alcohols [MESH:D005233] (529) 
 Butanols [MESH:D000440] (65)
F. Psychiatry and Psychology 
F. Psychiatry and Psychology
 Mental Disorders [MESH:D001523] (2063) 
 Sleep Disorders [MESH:D012893] (148) 
 Parasomnias [MESH:D020447] (57) 
 Sleep Arousal Disorders [MESH:D020921] (46) 
 Somnambulism [MESH:D013009] (44) 
 Epilepsy, Nocturnal Frontal Lobe, Type 4 [MESH:C563679] (43)